Picture of Prostatype Genomics AB logo

PROGEN Prostatype Genomics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Prostatype Study Results To Be Presented At World's Top Urology Meeting

Aug 24 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * PROSTATYPE ® P-SCORE AND PROGNOSTIC EVALUATION IN PROSTATE
CANCER TO BE PRESENTED AT THE LARGEST UROLOGY MEETING IN THE
WORLD
    * P-SCORE HAS SHOWN BETTER PREDICTION PERFORMANCE FOR
PROSTATE
CANCER-SPECIFIC DEATH AND METASTASIS THAN EAU RISK
CLASSIFICATION

Source text for Eikon:  ID:nWkr1Gjmn7 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Prostatype Genomics AB

See all news